Brandon Couillard
Stock Analyst at Wells Fargo
(4.47)
# 274
Out of 5,124 analysts
177
Total ratings
61.54%
Success rate
16.4%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Overweight | $70 → $76 | $66.78 | +13.81% | 3 | Feb 6, 2026 | |
| MLAB Mesa Laboratories | Maintains: Equal-Weight | $83 → $94 | $93.27 | +0.78% | 5 | Feb 4, 2026 | |
| RVTY Revvity | Maintains: Equal-Weight | $107 → $110 | $101.59 | +8.28% | 4 | Feb 3, 2026 | |
| WAT Waters | Maintains: Equal-Weight | $385 → $415 | $381.29 | +8.84% | 7 | Dec 15, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $635 → $675 | $542.83 | +24.35% | 8 | Dec 15, 2025 | |
| RGEN Repligen | Maintains: Overweight | $175 → $190 | $142.18 | +33.63% | 3 | Dec 15, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,450 | $1,373.57 | +5.56% | 7 | Dec 15, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Overweight | $4 → $4.5 | $3.14 | +43.31% | 2 | Dec 15, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $230 → $240 | $216.61 | +10.80% | 5 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $48 → $55 | $41.93 | +31.17% | 7 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $190 → $205 | $203.04 | +0.97% | 3 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $120 | $101.85 | +17.82% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $155 | $84.29 | +83.89% | 6 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $18 | $19.47 | -7.55% | 4 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $110 | $90.61 | +21.40% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $175 | $129.58 | +35.05% | 25 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $90 → $105 | $103.18 | +1.76% | 19 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $6.5 | $5.13 | +26.71% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $301.50 | +12.77% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $302.34 | +12.46% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $11.26 | +42.10% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $187.60 | +38.59% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $79.77 | +0.29% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $29.10 | -20.96% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.03 | +540.39% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.71 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.33 | +727.07% | 2 | Oct 13, 2017 |
Bio-Techne
Feb 6, 2026
Maintains: Overweight
Price Target: $70 → $76
Current: $66.78
Upside: +13.81%
Mesa Laboratories
Feb 4, 2026
Maintains: Equal-Weight
Price Target: $83 → $94
Current: $93.27
Upside: +0.78%
Revvity
Feb 3, 2026
Maintains: Equal-Weight
Price Target: $107 → $110
Current: $101.59
Upside: +8.28%
Waters
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $385 → $415
Current: $381.29
Upside: +8.84%
Thermo Fisher Scientific
Dec 15, 2025
Maintains: Overweight
Price Target: $635 → $675
Current: $542.83
Upside: +24.35%
Repligen
Dec 15, 2025
Maintains: Overweight
Price Target: $175 → $190
Current: $142.18
Upside: +33.63%
Mettler-Toledo International
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $1,400 → $1,450
Current: $1,373.57
Upside: +5.56%
Maravai LifeSciences Holdings
Dec 15, 2025
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.14
Upside: +43.31%
Danaher
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $230 → $240
Current: $216.61
Upside: +10.80%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $48 → $55
Current: $41.93
Upside: +31.17%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $190 → $205
Current: $203.04
Upside: +0.97%
Dec 15, 2025
Maintains: Overweight
Price Target: $93 → $120
Current: $101.85
Upside: +17.82%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $140 → $155
Current: $84.29
Upside: +83.89%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $14 → $18
Current: $19.47
Upside: -7.55%
Dec 1, 2025
Initiates: Equal-Weight
Price Target: $110
Current: $90.61
Upside: +21.40%
Nov 25, 2025
Maintains: Overweight
Price Target: $150 → $175
Current: $129.58
Upside: +35.05%
Nov 24, 2025
Downgrades: Hold
Price Target: $90 → $105
Current: $103.18
Upside: +1.76%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $5.13
Upside: +26.71%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $301.50
Upside: +12.77%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $302.34
Upside: +12.46%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $11.26
Upside: +42.10%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $187.60
Upside: +38.59%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $79.77
Upside: +0.29%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $29.10
Upside: -20.96%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $2.03
Upside: +540.39%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.71
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.33
Upside: +727.07%